Dyskinesia in a Prepubertal Boy After the First Dose of Methylphenidate and the Association of Focal Epileptiform Activity: A Case Report

Cevikaslan A., DUMAN Ö., Kutluk M. G.

ERCIYES MEDICAL JOURNAL, cilt.42, sa.4, ss.480-482, 2020 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 42 Sayı: 4
  • Basım Tarihi: 2020
  • Doi Numarası: 10.14744/etd.2019.04317
  • Dergi Adı: ERCIYES MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Academic Search Premier, CAB Abstracts, EMBASE, Veterinary Science Database, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.480-482
  • Anahtar Kelimeler: Dyskinesia, methylphenidate, movement disorder, Attention-Deficit/Hyperactivity Disorder, ADHD
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Background: Methylphenidate is a piperidine derivative stimulant drug. It inhibits the reuptake of dopamine and norepinephrine and improves the primary symptoms of Attention-Deficit/Hyperactivity Disorder. Methylphenidate may cause dyskinesias in children with Attention-Deficit/Hyperactivity Disorder, and concomitant irregularity in Electroencephalography may increase the likelihood of the neuropsychiatric side effects.